Skip to main content
. 2011 Oct;164(4):1079–1106. doi: 10.1111/j.1476-5381.2011.01302.x

Table 4.

Neurobiologically/neuropharmacologically based therapies in EAE

General approach class Treatment type Effects in EAE References
Ion channel-based approaches Na channel blockers (e.g. lamotrigine, flecainide), Na channel knockout mice Improvement (Bechtold et al., 2004; 2006; Black et al., 2006; O'Malley et al., 2009)
K Channel blockade Improvement (Judge et al., 1997; Strauss et al., 2000; Beeton et al., 2001; Madsen et al., 2005; Reich et al., 2005)
Ca channel blockade Improvement (Brand-Schieber and Werner, 2004; Tokuhara et al., 2010)
ASIC channel blockers (e.g. amiloride), ASIC knockouts Improvement (Friese et al., 2007)
Neurotransmitter-based approaches Dopamine signalling, increase in dopamine levels Improvement (Dijkstra et al., 1994)
Dopamine depletion (e.g. MPTP) Worsening (Balkowiec-Iskra et al., 2007)
Noradrenaline increase Improvement (Simonini et al., 2010)
Serotonin increase Improvement (Weistock et al., 1977; Scott et al., 1982; Vollmar et al., 2009)
Glutamate receptor antagonism Improvement (Wallstrom et al., 1996; Paul and Bolton, 2002; Gilgun-Sherki et al., 2003)
Neuropeptides Substance P antagonism, Substance P receptor (NK1) knockout mice Improvement (Nessler et al., 2006; Reinke et al., 2006)
Neuropeptide Y Improvement (Bedoui et al., 2003; Luhder et al., 2009)
Cannabinoids CB1 and CB2 receptor agonism Improvement (Arevalo-Martin et al., 2003; Pryce et al., 2003; Zajicek et al., 2003; Ni et al., 2004; Maresz et al., 2005; Rog et al., 2005; Freeman et al., 2006; Wissel et al., 2006; Centonze et al., 2007; Collin et al., 2007; Palazuelos et al., 2008; Zhang et al., 2009)
Cell-based therapies Neural stem cells Improvement (Picard-Riera et al., 2002; Einstein et al., 2003; Pluchino et al., 2003; 2005; Einstein et al., 2006; Makar et al., 2008; Pluchino et al., 2009; Yang et al., 2009)
Mesenchymal stem cells Improvement (Zappia et al., 2005; Kassis et al., 2008; Schafer et al., 2008; Bai et al., 2009; Lanza et al., 2009; Lu et al., 2009; Rafei et al., 2009; Freedman et al., 2010;Gordon et al., 2010; Karussis et al., 2010; Yamout et al., 2010)